A 36-week three-center double-blind randomized cross-over trial comparing metabolic effects of candesartan, hydrochlorothiazide and placebo
Phase of Trial: Phase II
Latest Information Update: 15 Aug 2011
At a glance
- Drugs Candesartan cilexetil; Hydrochlorothiazide
- Indications Hypertension
- Focus Pharmacodynamics
- Acronyms MEDICA
- 01 Dec 2008 Results published in Hypertension, according to 1134299.
- 15 Oct 2008 Checked against ClinicalTrials.gov record, last updated 15 October 2008.
- 07 Sep 2008 Results reported at EASD 2008.